Danish (OMX) Biotech Industry Analysis

UpdatedMar 05, 2026

DataAggregated Company Financials

Companies5

7D-1.5%
3M-14.8%
1Y-2.0%
YTD-11.5%

Over the last 7 days, the Biotech industry has remained flat, although notably Zealand Pharma gained 3.2%. In line with that, the industry has also been flat over the past 12 months. Looking forward, earnings are forecast to decline by 2.0% per year.

Industry Valuation and Performance

Has the Danish Biotech Industry valuation changed over the past few years?

Date	Market Cap	Revenue	Earnings	PE	Absolute PE	PS
Thu, 05 Mar 2026	DKK 151.6b	DKK 40.0b	DKK 15.0b	6x	10.1x	3.8x
Sat, 31 Jan 2026	DKK 169.6b	DKK 40.2b	DKK 18.8b	6.1x	9x	4.2x
Mon, 29 Dec 2025	DKK 180.1b	DKK 40.5b	DKK 18.9b	6.1x	9.5x	4.4x
Wed, 26 Nov 2025	DKK 174.8b	DKK 40.9b	DKK 19.1b	5.9x	9.1x	4.3x
Fri, 24 Oct 2025	DKK 171.5b	DKK 39.1b	DKK 16.8b	13.3x	10.2x	4.4x
Sun, 21 Sep 2025	DKK 162.9b	DKK 38.8b	DKK 16.7b	12.7x	9.7x	4.2x
Tue, 19 Aug 2025	DKK 139.8b	DKK 38.7b	DKK 16.7b	10.6x	8.4x	3.6x
Thu, 17 Jul 2025	DKK 127.3b	DKK 27.0b	DKK 7.4b	11.3x	17.3x	4.7x
Sat, 14 Jun 2025	DKK 138.2b	DKK 27.2b	DKK 7.4b	11.6x	18.7x	5.1x
Mon, 12 May 2025	DKK 125.9b	DKK 28.0b	DKK 7.9b	10.1x	15.9x	4.5x
Wed, 09 Apr 2025	DKK 124.1b	DKK 27.3b	DKK 7.7b	11x	16.1x	4.5x
Fri, 07 Mar 2025	DKK 156.8b	DKK 27.3b	DKK 7.7b	13.2x	20.4x	5.7x
Sun, 02 Feb 2025	DKK 158.5b	DKK 26.0b	DKK 4.7b	16.5x	33.8x	6.1x
Tue, 31 Dec 2024	DKK 160.9b	DKK 26.0b	DKK 4.7b	16.7x	34.3x	6.2x
Thu, 28 Nov 2024	DKK 161.6b	DKK 26.0b	DKK 4.7b	16.7x	34.4x	6.2x
Sat, 26 Oct 2024	DKK 179.0b	DKK 25.5b	DKK 5.5b	21.3x	32.7x	7x
Mon, 23 Sep 2024	DKK 191.9b	DKK 25.5b	DKK 5.5b	23.3x	35.1x	7.5x
Wed, 21 Aug 2024	DKK 200.6b	DKK 26.1b	DKK 5.7b	21x	35x	7.7x
Fri, 19 Jul 2024	DKK 193.1b	DKK 24.8b	DKK 5.6b	18.2x	34.3x	7.8x
Sun, 16 Jun 2024	DKK 172.3b	DKK 24.8b	DKK 5.6b	17.2x	30.6x	6.9x
Tue, 14 May 2024	DKK 180.7b	DKK 24.8b	DKK 5.7b	18.3x	31.9x	7.3x
Thu, 11 Apr 2024	DKK 186.2b	DKK 23.9b	DKK 5.0b	19.6x	36.9x	7.8x
Sat, 09 Mar 2024	DKK 193.7b	DKK 23.9b	DKK 5.0b	19.9x	38.5x	8.1x
Mon, 05 Feb 2024	DKK 166.2b	DKK 23.3b	DKK 4.2b	22.8x	39.9x	7.1x
Wed, 03 Jan 2024	DKK 177.7b	DKK 23.3b	DKK 4.2b	26.3x	42.7x	7.6x
Fri, 01 Dec 2023	DKK 174.6b	DKK 23.3b	DKK 4.2b	25.4x	41.9x	7.5x
Sun, 29 Oct 2023	DKK 158.4b	DKK 22.0b	DKK 4.7b	18.5x	33.4x	7.2x
Tue, 26 Sep 2023	DKK 195.9b	DKK 22.0b	DKK 4.7b	23x	41.4x	8.9x
Thu, 24 Aug 2023	DKK 196.3b	DKK 22.0b	DKK 4.7b	23.4x	41.6x	8.9x
Sat, 22 Jul 2023	DKK 211.1b	DKK 19.5b	DKK 4.4b	41.8x	47.9x	10.8x
Mon, 19 Jun 2023	DKK 208.1b	DKK 19.5b	DKK 4.4b	44x	47.2x	10.6x
Wed, 17 May 2023	DKK 217.6b	DKK 17.9b	DKK 4.0b	33.6x	54.4x	12.2x
Fri, 14 Apr 2023	DKK 207.1b	DKK 17.9b	DKK 3.5b	32.3x	58.6x	11.6x
Sun, 12 Mar 2023	DKK 189.1b	DKK 17.9b	DKK 3.5b	29.2x	53.3x	10.6x

Price to Earnings Ratio

53.3x

Sun, 12 Mar 2023

Current Industry PE

Investors are pessimistic on the Danish Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.

The industry is trading at a PE ratio of 10.4x which is lower than its 3-year average PE of 30.7x.

The 3-year average PS ratio of 6.9x is higher than the industry's current PS ratio of 3.9x.

Past Earnings Growth

The earnings for companies in the Biotechs industry have grown 61% per year over the last three years.
Revenues for these companies have grown 30% per year.
This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.